1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
In Situ Detection of Programmed Cell Death Protein 1 and Programmed Death Ligand 1 Interactions as a Functional Predictor for Response to Immune Checkpoint Inhibition in NSCLC
2025) In Journal of Thoracic Oncology(
- Contribution to journal › Article
- 2020
-
Mark
Granzyme B degraded type IV collagen products in serum identify melanoma patients responding to immune checkpoint blockade
(
- Contribution to journal › Article
- 2019
-
Mark
Is immunotherapy the holy grail for pancreatic cancer?
(
- Contribution to journal › Debate/Note/Editorial